|
Abstract: . . . in a sheep model of transvenous atrial defibrillation. Circu- lation 1994; 89: 413-22. 29. Boriani G, Biffi M, Zannoli R, Branzi A, Magnani B. Eval- uation of atrial refractoriness and atrial fibrillation inducibility immediately after internal atrial cardioversion in patients with chronic persistent atrial fibrillation . Cardiovasc Drugs Ther 1999; 13: 507-11. S116 . . . . . . lation 1994; 89: 413-22. 29. Boriani G, Biffi M, Zannoli R, Branzi A, Magnani B. Eval- uation of atrial refractoriness and atrial fibrillation inducibility immediately after internal atrial cardioversion in patients with chronic persistent atrial fibrillation . Cardiovasc Drugs Ther 1999; 13: 507-11. S116 . . . . . . model of transvenous atrial defibrillation. Circu- lation 1994; 89: 413-22. 29. Boriani G, Biffi M, Zannoli R, Branzi A, Magnani B. Eval- uation of atrial refractoriness and atrial fibrillation inducibility immediately after internal atrial cardioversion in patients with chronic persistent atrial fibrillation . Cardiovasc Drugs Ther 1999; 13: 507-11. S116 . . . . . . lation 1994; 89: 413-22. 29. Boriani G, Biffi M, Zannoli R, Branzi A, Magnani B. Eval- uation of atrial refractoriness and atrial fibrillation inducibility immediately after internal atrial cardioversion in patients with chronic persistent atrial fibrillation . Cardiovasc Drugs Ther 1999; 13: 507-11. S116 . . . . . . 1994; 89: 413-22. 29. Boriani G, Biffi M, Zannoli R, Branzi A, Magnani B. Eval- uation of atrial refractoriness and atrial fibrillation inducibility immediately after internal atrial cardioversion in patients with chronic persistent atrial fibrillation . Cardiovasc Drugs Ther 1999; 13: 507-11. S116 . . . --2689,5,269,2261,13445
|